Arvee Laboratories Complete Financial Statements

In FYNone, Arvee Laboratories (ARVEE) reported revenue ₹27 Cr, net profit ₹1 Cr and EPS ₹0.40, with a net profit margin of 5.3% and ROE of 6.5%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see ARVEE share price.

11 Years of Data
2025 - 2015

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 5.26% 2025 data
EBITDA Margin 10.53% 2025 data
Operating Margin 9.00% 2025 data
Return on Assets 5.26% 2025 data
Return on Equity 6.45% 2025 data

Balance Sheet Ratios

Current Ratio 11.00 2025 data
Debt to Equity 1.23 2025 data
Equity Ratio 81.58% 2025 data
Asset Turnover 1.00 2025 data

ARVEE Revenue, Net Profit & EBITDA — Year-on-Year Growth

ARVEE YoY (March 2025 vs Period) — revenue -28.9%, net profit -50.0%, EBITDA -50.0%, expenses -28.6%.

Revenue Growth
-28.9%
Year-over-Year
Net Profit Growth
-50.0%
Year-over-Year
EBITDA Growth
-50.0%
Year-over-Year
Expense Growth
-28.6%
Year-over-Year
Equity Growth
+6.9%
Year-over-Year
Operating Cash Flow Growth
+33.3%
Year-over-Year
Investing Cash Flow Growth
-100.0%
Year-over-Year
Financing Cash Flow Growth
+100.0%
Year-over-Year

ARVEE Income Statement — Revenue, EBITDA & Net Profit

Arvee Laboratories revenue ₹27 Cr, EBITDA ₹2 Cr, net profit ₹1 Cr, EPS ₹0.40 (None) — net profit margin 5.3%. Explore Arvee Laboratories intrinsic price to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017
Revenue 27 38 31 63 41 48 46 55 48 35
Expenses 25 35 27 54 35 41 39 49 41 29
EBITDA 2 4 4 9 6 7 6 7 7 6
Operating Profit Margin % 4.00% 9.00% 10.00% 12.00% 14.00% 13.00% 13.00% 11.00% 15.00% 17.00%
Depreciation 1 1 2 2 2 2 2 2 2 2
Interest 0 0 0 0 0 1 1 2 3 4
Profit Before Tax 1 3 2 6 3 4 3 3 2 1
Tax 0 1 1 2 1 1 1 0 1 -1
Net Profit 1 2 1 4 3 3 2 2 1 2
Earnings Per Share (₹) 0.40 1.95 0.95 3.74 2.34 2.43 4.17 4.11 2.58 3.83

ARVEE Balance Sheet — Assets, Liabilities & Shareholders' Equity

ARVEE total assets ₹38 Cr, total equity ₹31 Cr, total liabilities ₹38 Cr (2025) — ROE 6.5%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017
ASSETS
Total Assets 38 38 39 39 41 34 37 44 36
Current Assets 22 17 22 24 26 18 21 27 19
Fixed Assets 16 13 13 14 14 13 13 15 17
Capital Work in Progress 1 3 2 1 1 2 2 1 0
Investments 5 0 0 0 2 3 2 0 0
Other Assets 0 23 25 24 24 16 20 28 19
LIABILITIES
Total Liabilities 38 38 39 39 41 34 37 44 36
Current Liabilities 2 2 2 1 1 2 4 9 17
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 31 29 28 24 21 19 17 14 4
Share Capital 11 11 11 11 11 6 6 6 4
Reserves & Surplus 20 18 17 13 10 13 11 9 0

ARVEE Cash Flow Statement — Operating, Investing & Financing

Arvee Laboratories operating cash flow ₹4 Cr, investing ₹-2 Cr, financing ₹0 Cr, net cash flow ₹1 Cr (2024).

Periods ₹ Crores
Particulars March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 4 3 1 2 10 10 6 4 6 9
Investing Activities -2 -1 0 -1 -3 -3 -1 -1 -5 -6
Financing Activities 0 -2 -6 5 -10 -5 -4 -3 -1 -2
Net Cash Flow 1 -1 -5 6 -3 2 1 0 0 1